Medialization thyroplasty for cancer-related unilateral vocal fold paralysis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 17321874.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To justify the application of medialization thyroplasty in Chinese patients with symptomatic cancer-related unilateral vocal fold paralysis (UVFP). Retrospective chart review from February 2000 to March 2006. Eighty-seven Chinese patients undergoing medialization thyroplasty for UVFP were included; there were no significant differences between the cancer-related and benign groups in terms of the speech and swallowing rehabilitation outcome and the perioperative complication rate (P > 0.05). The median survival time of cancer-related UVFP patients from the date of medialization to death was 129 days. Age more than 65 years was identified as the only factor for a shorter survival period after medialization (P = 0.040). Medialization thyroplasty restores satisfactory speech and swallowing and has a low perioperative complication rate in Chinese patients with cancer-related UVFP. Postmedialization survival period was also reasonable. Medialization thyroplasty is a justifiable treatment option for cancer-related UVFP.
Medical subject headings
- Neoplasms
- Thyroid Cartilage
- Vocal Cord Paralysis